NPPB and pulmonary arterial hypertension: BNP is a hormone released in response to increased cardiac load and serves as a biomarker for heart failure, whereas the 6MWD is a commonly utilized clinical indicator for assessing patient exercise tolerance and cardiopulmonary function and is crucial in evaluating PAH.